Age-Specific Seroprevalence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infection Among Injection Drug Users Admitted to Drug Treatment in 6 US Cities

Bibliographic Data

ID11030809
AuthorsChristopher S Murrill (0000-0001-5150-7547, Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Howard Weeks (Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Brian C Castrucci (0000-0002-4117-2832, Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Hillard Weinstock (National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Hillard S Weinstock (Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Beth P Bell (Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Catherine Spruill (Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.), Marta Gwinn (0000-0002-7706-5174, Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.)
Year2002
Volume92
Issue3
Pages385-387
Publication date2002-03-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.92.3.385
PMID11867316
OpenAlexW2013515770
LanguageEN
Citations received10
References cited9

Objectives. This study measured age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus (HCV) infection among injection drug users (IDUs) admitted to drug treatment programs in 6 US cities. Methods. Remnant sera collected from persons entering treatment with a history of illicit drug injection were tested for antibodies to HIV, hepatitis C (anti-HCV), and hepatitis B core antigen (anti-HBc). Results. Prevalence of anti-HBc and anti-HCV increased with age and reached 80% to 100% among older IDUs in all 6 cities. Although overall age-specific HIV prevalence was lower than anti-HCV or anti-HBc, this prevalence was greater in the Northeast than in the Midwest and West. Conclusions. The need continues for effective primary prevention programs among IDUs specifically targeting young persons who have recently started to inject drugs. (Am J Public Health. 2002;92:385–387)

Antibody · Drug · Drug injection · Hepatitis · Hepatitis B · Hepatitis B virus · Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV) · Pathology · Public health · Serology · Seroprevalence · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Immunology · Internal Medicine · Medicine · Pharmacology · Virology

Tools

Open DOISci-Hub